These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Combined action of remantadine (amantadine) and ribavirin on experimental influenza]. Galegov GA; Knight V; Pushkarskaia NL; Wilson SZ; Couch RB Vopr Virusol; 1981; (6):697-701. PubMed ID: 7347232 [TBL] [Abstract][Full Text] [Related]
25. Protection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosol. Wyde PR; Wilson SZ; Gilbert BE; Smith RH Antimicrob Agents Chemother; 1986 Dec; 30(6):942-4. PubMed ID: 3813516 [TBL] [Abstract][Full Text] [Related]
26. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. Hall CB; McBride JT; Walsh EE; Bell DM; Gala CL; Hildreth S; Ten Eyck LG; Hall WJ N Engl J Med; 1983 Jun; 308(24):1443-7. PubMed ID: 6343860 [TBL] [Abstract][Full Text] [Related]
27. Aerosol therapy of influenza infections of mice and primates with rimantadine, ribavirin, and related compounds. Stephen EL; Walker JS; Dominik JW; Young HW; Berendt RF Ann N Y Acad Sci; 1977 Mar; 284():264-71. PubMed ID: 101109 [TBL] [Abstract][Full Text] [Related]
28. Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A. Cohen A; Togo Y; Khakoo R; Waldman R; Sigel M J Infect Dis; 1976 Jun; 133 Suppl():A114-120. PubMed ID: 778307 [TBL] [Abstract][Full Text] [Related]
29. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. Hall CB; McBride JT; Gala CL; Hildreth SW; Schnabel KC JAMA; 1985 Dec; 254(21):3047-51. PubMed ID: 3903239 [TBL] [Abstract][Full Text] [Related]
35. High dose-short duration ribavirin aerosol treatment--a review. Knight V; Gilbert BE; Wyde PR; Englund JA Bull Int Union Tuberc Lung Dis; 1991; 66(2-3):97-101. PubMed ID: 1756300 [TBL] [Abstract][Full Text] [Related]
36. Comparison of oral and aerosol ribavirin regimens in the high risk elderly. Bernstein JM; Liss H; Erk SD J Clin Pharmacol; 1989 Dec; 29(12):1128-34. PubMed ID: 2693503 [TBL] [Abstract][Full Text] [Related]
37. Response of influenza virus-infected mice to selected doses of ribavirin administered intraperitoneally or by aerosol. Berendt RF; Walker JS; Dominik JW; Stephen EL Antimicrob Agents Chemother; 1977 Jun; 11(6):1069-70. PubMed ID: 879752 [TBL] [Abstract][Full Text] [Related]
38. Ribavirin: a clinical overview. Fernandez H; Banks G; Smith R Eur J Epidemiol; 1986 Mar; 2(1):1-14. PubMed ID: 3021519 [TBL] [Abstract][Full Text] [Related]
39. Favorable outcome after treatment with amantadine and ribavirin in a pregnancy complicated by influenza pneumonia. A case report. Kirshon B; Faro S; Zurawin RK; Samo TC; Carpenter RJ J Reprod Med; 1988 Apr; 33(4):399-401. PubMed ID: 3367344 [TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) in a double-blind study during an outbreak of influenza. Salido-Rengell F; Nasser-Quinones H; Briseno-Garcia B Ann N Y Acad Sci; 1977 Mar; 284():272-7. PubMed ID: 360901 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]